Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
48 Cards in this Set
- Front
- Back
- 3rd side (hint)
Learning objective 1 |
Discuss the chemical consequences of mutations which result in inborn errors of metabolism |
|
|
Discuss the chemical consequences of mutations which result in inborn errors of metabolism
General outcome |
A critical step in a metabolic step is affected |
|
|
Discuss the chemical consequences of mutations which result in inborn errors of metabolism
Effects |
1. Accumulation 2. End product 3. Alternate pathways |
1. Accumulation of normally metabolized chemical
2. No or decreased end product
3. Alternate pathways is activated, sometimes it can produce toxic products |
|
Learning objective 2 |
List examples of diseases in which there is a genetic defect resulting in an error in amino acid metabolism, carbohydrate metabolism, lipid metabolism and nucleic acid metabolism
cont. |
Describe the mode of inheritance, genetic defect major symptoms, treatment and detection of each disorder |
|
4 types of pathway that can have metabolic defects |
Amino acid, carbohydrate, lipid and nucleic acid metabolism |
|
|
Defects in amino acid metabolism
Examples |
PKU Albinism Alkaptonuria |
|
|
PKU
Mode of inheritance |
Autosomal ________ |
Autosomal recessive |
|
PKU
Genetic defect |
Deficiency in the enzyme.
Enzyme name? |
phenylalanine hydroxylase |
|
PKU Phenylalanine enzyme
Notes: Function |
PHE to tyrosine |
it is blocked |
|
PKU Symptoms |
Brain ____ mental _________ neurological ________ |
brain damage retardation symptoms |
|
PKU
Symptoms Onset |
Brain damage mental retardation neurological symptoms
Onset? |
2 to 3 months of age |
|
PKU
treatment |
Restricting dietary intake of ___. |
Phe |
|
PKU
Detection |
Early detection is _____, state laws ____ testing of all ___. |
important require newborns |
|
Albinism
Type of error |
Amino acid metabolism |
|
|
Albinism
Mode of inheritance |
Autosomal recessive |
|
|
Albinism
Defect major symptoms |
Defect: lack of activity of tyrosine Tyrosine to DOPA
Lack of ________ in the ___________. |
pigment skin hair eyes
poor vision, extreme sensitivity to sunlight. |
|
Albinism
Treatment |
Y/N |
None |
|
Alkaptonuria
Notes: incidence |
1st defect characterized as an inborn error of metabolism |
|
|
Alkaptonuria
Mode of inheritance |
Autosomal recessive |
|
|
Alkapotnuria
Genetic defect |
Deficiency in homogentistic acid oxidase |
Conversion of homogentistic acid to maleylacetoacetic acid is locked
Excess h acid and seen in urine |
|
Alkapotnuria
Major symptoms |
_____ urine
______ due to deposition of ________________________ in _______ |
black urine
arthritis due to deposition of hmogentistic acid in cartilage |
|
Alkapotnuria
Treatment and detection |
Not mentioned |
|
|
Defect in carbohydrate metabolism
List |
Galactosemia |
|
|
Galactosemia
Mode of inheritance |
Autosomal recessive |
|
|
Galactosemia
Genetic defect |
Deficiency in galactose1-phosphate uridyl transferase |
Coded by multiple allele with different severity
Normal-50%to zero |
|
Galactosemia
Major symptoms |
___ distrubances ___hydration ______ of appetite
If untreated, can progress to ________, _______ formation and ____ due to accumulation of other __________. |
GI distrubances Dehydration Loss of appetite
If untreated, can progress to jaundice, cataract formation and MR due to accumulation of other product. |
|
Galactosemia
Treatment |
Galactose-free diet Lactose free milk
for how long? |
Lifelong |
|
Defects in lipid and lipoprotein metabolism
List |
Tay-Sachs disease Familial hypercholesterolemia |
|
|
Tay-Sachs disease
Mode of inheritance |
autosomal recesive |
|
|
Tay-Sachs disease
Defects |
Deficiency in hexominidase A
Notes: results |
Reaction that splits off the terminal sugar group, hexosamine from ganglioside GM2 in nerve cell membrane is blocked
High concentrations of GM2 accumulate in the brain and the nervous system |
|
Tay-Sachs disease
Symptoms |
Normal at ____
By 6 months, _____, show __________ in ______, startle reaction to sudden __________, progressive loss of______ function, loss ability to ____ and ____.
Usually die by ________ |
Normal at birth
By 6 months, weak, show difficulty in feeding, startle reaction to sudden noises, progressive loss of motor fuction, loss ability to see and hear.
3 years old |
|
Tay-Sachs disease
Treatment |
N |
|
|
Tay-sachs disease
Detection |
screen for carriers by _______________________________________________
Detect ___________ through _______ |
Screen for carriers by measuring hexosamindase A levels in blood of high risk individuals
Detect abnormal fetuses through amniocentesis |
|
Familial Hypercholesterolemia
Type of error |
lipid |
|
|
Familial Hypercholestrolemia
Mode of inheritance |
autosomal dominant |
|
|
Familial Hypercholestolemia
Defect |
_______ in _____ for _______ |
mutation in gene coding for LDL receptors |
|
Familial hypercholesterolemia
Lack of LDL receptors
Result |
defective transport of cholesterol into cells
High cholesterol levels in blood
Cholesterol deposits in arteries |
|
|
FH
Symptoms: Heterozygotes |
Have 1/2 the number of normal receptors and at least 2x normal concentration of LDLI n blood
Increased risk for heart attacks |
|
|
FH
Symptoms: homozygous |
No functional receptors Cholesterol concentration is 4 to 6x normal.
Heart attack begins as early as 2 and death usually occurs by age 30 |
|
|
FH
Treatment |
Diet Drugs to lower LDL |
|
|
FH
Detection |
Measure LDL receptor activity in cultured fetal amniotic cells of homozygous |
|
|
Disorder of nucleic acid metabolism
List |
Lesch-Nyhan syndrome |
|
|
Lesch-Nyhan syndrome
Mode of inheritance |
X-linked recessive |
|
|
Lesch-Nyhan syndrome
Defect |
mutation in HGPRT gene, an enzyme in the pathway of purine synthesis
Result |
HGPRT: hypoxanthie guanine pphosphribosyl transferase
purine accumulates and converted to uric acid |
|
Lesch-Nyhan syndrome
Symptoms |
Renal failure Spastic movements MENTAL retardation Strong tendency for self mutilation |
|
|
Lesch-Nyhan syndrome
Progression |
progressive and fatal |
|
|
Lesch-Nyhan syndrome
Treatment |
Drugs
Mechanism |
Drugs to reduce uric acid levels and kidney damage; no treatment for neurologic symptoms |
|
Lesch-Nyhan syndrome
Detection |
Measurement of ___________ activity in ____________ to detect ____ and in _________from _____. |
measurement of HGPRT enzymes activity in hair follicles to detect carriers and in amniotic cells from fetuses |